Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 53,667 9.600% |
53,667 (New Position) |
Filing History |
| 2023-02-08 06:08 am Purchase |
2022-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 6,686 7.600% |
6,686 (New Position) |
Filing History |
| 2023-02-08 06:07 am Unchanged |
2022-12-31 | 13G | Globus Maritime Limited GLBS |
Mitchell P. Kopin | 1,959,250 8.700% |
0 (Unchanged) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 90,204 5.600% |
82,687 (+1100.00%) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Histogen Inc. HSTO |
Mitchell P. Kopin | 240,375 5.300% |
240,375 (New Position) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Mitchell P. Kopin | 19,197 9.000% |
19,197 (New Position) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Hoth Therapeutics, Inc. HOTH |
Mitchell P. Kopin | 57,008 4.200% |
57,008 (New Position) |
Filing History |
| 2023-02-08 06:06 am Sale |
2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 54,600 6.300% |
-14,007 (-20.42%) |
Filing History |
| 2023-02-08 06:06 am Sale |
2022-12-31 | 13G | Helius Medical Technologies, Inc. HSDT |
Mitchell P. Kopin | 40 5.100% |
-27 (-40.00%) |
Filing History |
| 2023-02-08 06:06 am Purchase |
2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 916 9.400% |
916 (New Position) |
Filing History |
| 2023-02-08 06:06 am Purchase |
2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Mitchell P. Kopin | 27,092 5.100% |
27,092 (New Position) |
Filing History |
| 2023-02-08 06:06 am Unchanged |
2022-12-31 | 13G | Guardion Health Sciences, Inc. GHSI |
Mitchell P. Kopin | 5,000,000 7.500% |
0 (Unchanged) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | Synaptogenix, Inc. SNPX |
Mitchell P. Kopin | 31,468 9.990% |
31,468 (New Position) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 1,918,959 9.990% |
687,477 (+55.83%) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL |
Mitchell P. Kopin | 540 9.990% |
227 (+72.64%) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | Palisade Bio, Inc. PALI |
Mitchell P. Kopin | 8,739 5.700% |
8,739 (New Position) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | Aditxt, Inc. ADTX |
Mitchell P. Kopin | 1 5.800% |
0 (+1.38%) |
Filing |
| 2022-12-09 08:20 am Purchase |
2022-11-30 | 13G | WiSA Technologies, Inc. WISA |
Mitchell P. Kopin | 236 4.990% |
209 (+775.30%) |
Filing History |
| 2022-10-17 06:01 am Purchase |
2022-10-11 | 13G | Avenue Therapeutics, Inc. ATXI |
Mitchell P. Kopin | 2,891 4.990% |
2,891 (New Position) |
Filing History |
| 2022-09-26 06:20 am Purchase |
2022-09-16 | 13G | Aditxt, Inc. ADTX |
Mitchell P. Kopin | 1 9.990% |
1 (New Position) |
Filing |